Cote-Sierra, J., Bredan, A., Toldos, C. M., Stijlemans, B., Brys, L., Cornelis, P., . . . Revets, H. (2002). Bacterial Lipoprotein-Based Vaccines Induce Tumor Necrosis Factor-Dependent Type 1 Protective Immunity against Leishmania major. American Society for Microbiology.

Cote-Sierra, Javier, Amin Bredan, Carmen M. Toldos, Benoit Stijlemans, Lea Brys, Pierre Cornelis, Manuel Segovia, Patrick de Baetselier, and Hilde Revets. Bacterial Lipoprotein-Based Vaccines Induce Tumor Necrosis Factor-Dependent Type 1 Protective Immunity against Leishmania Major. American Society for Microbiology, 2002.

Cote-Sierra, Javier, et al. Bacterial Lipoprotein-Based Vaccines Induce Tumor Necrosis Factor-Dependent Type 1 Protective Immunity against Leishmania Major. American Society for Microbiology, 2002.